$TRUP

Qureshi Fawwad sold $133K of TRUP

Qureshi Fawwad (Chief Financial Officer) sold 6,007 shares of TRUPANION, INC. (TRUP) at $22.17 ($0.13M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Qureshi Fawwad
Published May 28, 2026, 1:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralMed
01

Why it matters

The disclosure may cause short-lived sentiment noise, but 10b5-1 plans generally reduce the likelihood that the trade signals a change in company outlook.

02

Market read

A disclosed CFO sale in TRUP under a 10b5-1 plan is unlikely to be a standalone catalyst.

03

What to watch

The filing does not indicate whether other insiders or institutions increased/decreased positions around the same time, which could dominate price action.

Relevance 7/10Timing: Immediate (new SEC Form 4 filing dated 2026-05-27) but primarily informational.

Background

The article is an SEC EDGAR Form 4 disclosure of an insider transaction by TRUP’s CFO.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

TRUP’s CFO Qureshi Fawwad sold 6,007 shares in an open-market transaction ($133,169.78) under a pre-arranged 10b5-1 plan.

Expected impact

Near-term impact likely limited; any reaction may be modest unless accompanied by other company-specific news.

Evidence & confidence

This is a routine SEC Form 4 transaction with a stated pre-arranged 10b5-1 plan, providing disclosure without new fundamentals.

Market effects

Limited; single-officer 10b5-1 sale does not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is executed under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than negative expectations.

Key entities

  • TRUPANION, INC.

    Subject of the insider transaction; CFO sold shares under a 10b5-1 plan.

  • Qureshi Fawwad

    TRUP CFO who executed the open-market sale disclosed on Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended